Trials / Recruiting
RecruitingNCT07351669
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
The Performance of Spectral CT in Evaluating Treatment Response After Transarterial Chemoembolization for Hepatocellular Carcinoma: The SpecTRAIL Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Zhongda Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
By comparing the diagnostic accuracy of spectral CT and conventional CT in evaluating treatment response efficacy after TACE, this study aims to investigate the diagnostic performance of spectral CT in assessing treatment response following TACE for hepatocellular carcinoma.
Conditions
Timeline
- Start date
- 2026-01-20
- Primary completion
- 2027-12-31
- Completion
- 2028-06-30
- First posted
- 2026-01-20
- Last updated
- 2026-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07351669. Inclusion in this directory is not an endorsement.